Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia

被引：3
|
作者：
Lee, Benjamin J. J. [1 ,4 ]
Griffin, Shawn P. P. [1 ,2 ]
Doh, Jean [1 ]
Kongtim, Piyanuch [3 ]
Chan, Alexandre [1 ,2 ]
O'Brien, Susan [3 ]
Jeyakumar, Deepa [3 ]
Ciurea, Stefan O. O. [3 ]
机构：
[1] Univ Calif Irvine Hlth, Chao Family Comprehens Canc Ctr, Dept Pharm, Orange, CA 92868 USA
[2] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Dept Clin Pharm Practice, Irvine, CA USA
[3] Univ Calif Irvine Hlth, Chao Family Comprehens Canc Ctr, Dept Med, Div Hematol Oncol, Orange, CA 92868 USA
[4] Univ CaliforniaIrvine Hlth, Dept Pharm, 101 City Dr South,Bldg 23,Rm 275, Orange, CA 92868 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 05期
关键词：
D O I：
10.1002/ajh.26880
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E113 / E115
页数：3
相关论文
共 50 条
  • [1] The safety of concurrent intrathecal chemotherapy during blinatumomab in adults with acute lymphoblastic leukemia
    Ngo, Dat
    Otoukesh, Salman
    Stein, Anthony S.
    Forman, Stephen
    Pullarkat, Vinod
    Aldoss, Ibrahim
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2754 - 2756
  • [2] Case report of neurotoxicity with blinatumomab and concurrent intrathecal chemotherapy in second relapse of acute lymphoblastic leukemia with central nervous system disease
    Chen, Jason
    Ngo, Dat
    Rosenthal, Joseph
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 2027 - 2030
  • [3] Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
    Kantarjian, Hagop
    Stein, Anthony
    Goekbuget, Nicola
    Fielding, Adele K.
    Schuh, Andre C.
    Ribera, Josep-Maria
    Wei, Andrew
    Dombret, Herve
    Foa, Robin
    Bassan, Renato
    Arslan, Onder
    Sanz, Miguel A.
    Bergeron, Julie
    Demirkan, Fatih
    Lech-Maranda, Ewa
    Rambaldi, Alessandro
    Thomas, Xavier
    Horst, Heinz-August
    Brueggemann, Monika
    Klapper, Wolfram
    Wood, Brent L.
    Fleishman, Alex
    Nagorsen, Dirk
    Holland, Christopher
    Zimmerman, Zachary
    Topp, Max S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (09): : 836 - 847
  • [4] Blinatumomab in acute lymphoblastic leukemia
    Thomas, Xavier
    Lejeune, Caroline
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (03) : 251 - 253
  • [5] NEUROTOXICITY OF INTRATHECAL CHEMOTHERAPY FOR LEUKEMIA
    MARMONT, AM
    DAMASIO, EE
    BRITISH MEDICAL JOURNAL, 1973, 4 (5883): : 47 - 47
  • [6] FEASIBILITY OF ALTERNATIVE INTRATHECAL THERAPIES FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND ACUTE NEUROTOXICITY
    Andrews, Jennifer
    Bergsagel, John
    Lew, Glen
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 924 - 924
  • [7] Blinatumomab for the treatment of acute lymphoblastic leukemia
    Jason B. Kaplan
    Marina Grischenko
    Francis J. Giles
    Investigational New Drugs, 2015, 33 : 1271 - 1279
  • [8] Blinatumomab for Acute Lymphoblastic Leukemia Reply
    Kantarjian, Hagop
    Jabbour, Elias
    Topp, Max S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23): : E49 - U113
  • [9] Blinatumomab for the treatment of acute lymphoblastic leukemia
    Kaplan, Jason B.
    Grischenko, Marina
    Giles, Francis J.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (06) : 1271 - 1279
  • [10] Blinatumomab for treating acute lymphoblastic leukemia
    Ribera, Josep-Maria
    Vives, Susana
    Motllo, Cristina
    Jimenez-Lorenzo, Maria-Jose
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (04): : 477 - 485
12345